Merck & Co., Inc. (MRK) Stock Overview
NYSE · Healthcare · Drug Manufacturers - General
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair,…
Source: Yahoo Finance
Sector & Industry
Merck & Co., Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NYSE exchange.
Merck & Co., Inc. at a Glance
| Company | Merck & Co., Inc. |
| Ticker | MRK |
| Exchange | NYSE |
| Currency | USD |
| Price | $150.33 |
| Market cap | $370.89B |
| P/E ratio (trailing) | 120.26 |
| EPS (trailing) | $1.25 |
| 52-week high | $156.92 |
| 52-week low | $77.58 |
| Dividend yield | 2.23% |
| Ex-dividend date | 15 Sep 2026 |
| Beta | 0.23 |
| Return on equity (ROE) | 6.96% |
| Debt-to-equity | 128.41% |
| Average volume | 10.53M |
| Shares outstanding | 2.47B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 73,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
- What is Merck & Co., Inc.'s current P/E ratio?
- Merck & Co., Inc. (MRK) has a trailing P/E ratio of 120.26 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Merck & Co., Inc.'s market capitalisation?
- Merck & Co., Inc.'s market cap is $370.89B based on our latest snapshot. See how it ranks by market cap →
- What is MRK's 52-week range?
- Over the past 52 weeks, MRK has traded between $77.58 and $156.92. What does the 52-week range mean? →
- How volatile is Merck & Co., Inc. compared to the market?
- Merck & Co., Inc. has a beta of 0.23, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Merck & Co., Inc. pay a dividend?
- Merck & Co., Inc.'s trailing annual dividend yield is 2.23%. Compare with other high-yield stocks →
- What exchange is MRK listed on?
- MRK is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Merck & Co., Inc. in?
- Merck & Co., Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →